AUD 0.1
(4.4%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.48 Million | -2.34 Million | -1.09 Million | -903.51 Thousand | -693 Thousand | -1.1 Million |
Net Income | -3.71 Million | -3.08 Million | -1.04 Million | -1.1 Million | -984.73 Thousand | -1.37 Million |
Depreciation & Amortization | 31.02 Thousand | 1.49 Million | 18.31 Thousand | 778.00 | 1260.00 | 2502.00 |
Deferred income taxes | - | -418.91 Thousand | -98.72 Thousand | - | 86.13 Thousand | - |
Stock-based compensation | - | 659.13 Thousand | 25.83 Thousand | - | 61.17 Thousand | - |
Change in working capital | 239.78 Thousand | -240.22 Thousand | -156.62 Thousand | 83.96 Thousand | 174.92 Thousand | -297.97 Thousand |
Other non-cash items | 962.53 Thousand | -752.08 Thousand | 162.97 Thousand | 114.98 Thousand | -31.77 Thousand | 562.73 Thousand |
Investing Cash Flow | -7.11 Million | -4.27 Million | -2.41 Million | -539.79 Thousand | -467.49 Thousand | -733.3 Thousand |
Investments in PPE | -27.15 Thousand | -4.52 Million | -2.41 Million | -539.79 Thousand | -480.01 Thousand | -733.3 Thousand |
Acquisitions | - | - | - | - | 12.52 Thousand | - |
Investment purchases | - | -1.13 Million | - | - | - | - |
Sales/Maturities of investments | 150 Thousand | - | - | - | - | - |
Other Investing Activities | 1.29 Million | 1.38 Million | 2477.00 | 923.00 | 14.46 Thousand | 1324.00 |
Financing Cash Flow | 7.7 Million | 5.4 Million | 4.11 Million | 4.27 Million | 392.87 Thousand | 2.4 Million |
Debt repayment | -1.2 Million | -24.28 Thousand | -26.77 Thousand | -16.15 Thousand | -24.38 Thousand | -40 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -358.67 Thousand | -250.71 Thousand | -229.7 Thousand | -38.32 Thousand | - |
Common Stock Issuance | 6.52 Million | 5.78 Million | 4.14 Million | 4.34 Million | 490.14 Thousand | 2.24 Million |
Other Financing Activities | -25.08 Thousand | 5.4 Million | 4.11 Million | 409.4 Thousand | 2870.00 | 202 Thousand |
Accounts receivables | 10.61 Thousand | -240.22 Thousand | -69.19 Thousand | 61.83 Thousand | 130.28 Thousand | 39.42 Thousand |
Accounts payables | 231.88 Thousand | 44.57 Thousand | 32.93 Thousand | 22.12 Thousand | 19.55 Thousand | -349.62 Thousand |
Inventory | - | -121.95 Thousand | - | - | - | - |
Other working capital | -2714.00 | 77.38 Thousand | -120.36 Thousand | - | 25.09 Thousand | 12.22 Thousand |
Cash at beginning of period | 2.37 Million | 3.58 Million | 2.97 Million | 148.03 Thousand | 915.65 Thousand | 352.07 Thousand |
Cash at end of period | 473.39 Thousand | 2.37 Million | 3.58 Million | 2.97 Million | 148.03 Thousand | 915.65 Thousand |
Capital Expenditure | -27.15 Thousand | -4.52 Million | -2.41 Million | -539.79 Thousand | -480.01 Thousand | -733.3 Thousand |
Effect of forex changes on cash | - | 6095.00 | 6685.00 | - | - | 138.00 |
Net cash flow / Change in cash | -1.89 Million | -1.21 Million | 608.42 Thousand | 2.83 Million | -767.62 Thousand | 563.57 Thousand |
Free Cash Flow | -2.51 Million | -6.87 Million | -3.51 Million | -1.44 Million | -1.17 Million | -1.83 Million |
Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.23 Million | -2.48 Million | -2.28 Million | -3.08 Million | -806.03 Thousand | -1.04 Million |
Depreciation & Amortization | 15.44 Thousand | 15.57 Thousand | 15.05 Thousand | 1.49 Million | 14.15 Thousand | 18.31 Thousand |
Deferred income taxes | - | - | -194.41 Thousand | -418.91 Thousand | - | -98.72 Thousand |
Stock-based compensation | - | 1.27 Million | 434.63 Thousand | 659.13 Thousand | 224.5 Thousand | 25.83 Thousand |
Change in working capital | - | - | -162.84 Thousand | -240.22 Thousand | - | -156.62 Thousand |
Other non-cash items | 449.93 Thousand | -469.72 Thousand | 950.77 Thousand | -752.08 Thousand | -131.51 Thousand | 162.97 Thousand |
Investing Cash Flow | -2.87 Million | -4.21 Million | -2.97 Million | -4.27 Million | -1.35 Million | -2.41 Million |
Investments in PPE | 1.00 | -5.41 Million | -2.68 Million | -4.52 Million | -1.84 Million | -2.41 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -1.13 Million | -1.13 Million | - | - |
Sales/Maturities of investments | -870.91 Thousand | 1.02 Million | -487.08 Thousand | - | 487.08 Thousand | - |
Other Investing Activities | 1.14 Million | 1.2 Million | 1.33 Million | 1.38 Million | 497.37 Thousand | 2477.00 |
Financing Cash Flow | 2.11 Million | 5.5 Million | 209.14 Thousand | 5.4 Million | 5.19 Million | 4.11 Million |
Debt repayment | -1.2 Million | -13.04 Thousand | - | -24.28 Thousand | -11.06 Thousand | -26.77 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | -358.67 Thousand | - | -250.71 Thousand |
Common Stock Issuance | 916.8 Thousand | 5.6 Million | 222.36 Thousand | 5.78 Million | 5.2 Million | 4.14 Million |
Other Financing Activities | -12.04 Thousand | 5.51 Million | 209.14 Thousand | 5.4 Million | 5.2 Million | 4.11 Million |
Accounts receivables | - | - | -240.22 Thousand | -240.22 Thousand | - | -69.19 Thousand |
Accounts payables | - | - | - | 44.57 Thousand | - | 32.93 Thousand |
Inventory | - | - | - | -121.95 Thousand | - | - |
Other working capital | - | - | 77.38 Thousand | 77.38 Thousand | - | -120.36 Thousand |
Cash at beginning of period | 1.99 Million | 2.37 Million | 6.47 Million | 3.58 Million | 3.58 Million | 2.97 Million |
Cash at end of period | 473.39 Thousand | 1.99 Million | 2.37 Million | 2.37 Million | 6.47 Million | 3.58 Million |
Capital Expenditure | 1.00 | -5.41 Million | -2.68 Million | -4.52 Million | -1.84 Million | -2.41 Million |
Effect of forex changes on cash | - | -9498.00 | 6045.00 | 6095.00 | 50.00 | 6685.00 |
Net cash flow / Change in cash | -1.51 Million | -380.59 Thousand | -4.1 Million | -1.21 Million | 2.88 Million | 608.42 Thousand |
Free Cash Flow | -765.38 Thousand | -7.07 Million | -4.03 Million | -6.87 Million | -2.79 Million | -3.51 Million |
ECIA
5460
0917
RBX
3710
FLUOROCHEM